Official UK procurement notice
Provision of Seegene rapid in-house SARS CoV 2 Testing System and Variant of Concern (VOC) testing
Authority: Belfast Health and Social Care Trust (Central government)
What is being bought
Published requirement descriptionProvision of Seegene rapid in-house SARS CoV 2 Testing System and Variant of Concern (VOC) testing
CPV: Laboratory, optical and precision equipments (excl. glasses)
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Procedure terms & legal framework
From the official record- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 31 Aug 2021, 17:07 BST
- Last source update
- 4 Oct 2021, 15:07 BST
- Authority reference
DAC10068- FTS notice number
2021/S 000-024621- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02db6bFind a Tender
- Why no open competition
The works, supplies or services can be provided only by a particular economic operator due to absence of competition for technical reasons; Additional deliveries by the original supplier ordered under the strict conditions stated in the directive
- Published justification
No reasonable alternative exists for this procurement, it is in the public interest and is required to enable the Regional Virology Laboratory to meet Covid-19 surge testing requirements. The absence of competition is not a result of the artificial narrowing of the parameters of the procurement
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast| Awarded to | Value | Date | Status |
|---|---|---|---|
| Accuscience Limited | £300,000 †same award published again · counted once | — | Awarded |
| Accuscience Limited | £300,000 † | — | Awarded |
Contracts
Provision of Seegene rapid in-house SARS CoV 2 Testing System and Variant of Concern · Accuscience Limited
- Signed
- 21 Sept 2021
- Value
- £300,000
- Status
- active
Provision of Seegene rapid in-house SARS CoV 2 Testing System and Variant of Concern (VOC) testing · Accuscience Limited
- Signed
- 31 Aug 2021
- Value
- £300,000
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Belfast Health & Social Care TrustReview body
Bidders & participating suppliers
2 commercial parties on the notice- Accuscience LimitedAwarded supplier
- Accuscience LimitedAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.